These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23602690)

  • 21. Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia.
    Kishi T; Iwata N
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):343-54. PubMed ID: 23823741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of olanzapine in treatment-resistant schizophrenia.
    Zink M
    J Psychiatry Neurosci; 2005 Nov; 30(6):409-15. PubMed ID: 16327874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.
    Galling B; Vernon JA; Pagsberg AK; Wadhwa A; Grudnikoff E; Seidman AJ; Tsoy-Podosenin M; Poyurovsky M; Kane JM; Correll CU
    Acta Psychiatr Scand; 2018 Mar; 137(3):187-205. PubMed ID: 29431197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.
    Wang G; Zheng W; Li XB; Wang SB; Cai DB; Yang XH; Ungvari GS; Xiang YT; Correll CU
    J Psychiatr Res; 2018 Oct; 105():23-32. PubMed ID: 30144667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials.
    Rummel C; Kissling W; Leucht S
    Schizophr Res; 2005 Dec; 80(1):85-97. PubMed ID: 16183258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trials.
    Dold M; Fugger G; Aigner M; Lanzenberger R; Kasper S
    Schizophr Res; 2015 Aug; 166(1-3):187-93. PubMed ID: 26008883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective.
    Dold M; Leucht S
    Evid Based Ment Health; 2014 May; 17(2):33-7. PubMed ID: 24713315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials.
    Wang HR; Woo YS; Ahn HS; Ahn IM; Kim HJ; Bahk WM
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25770098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepines, benzodiazepine-like drugs, and typical antipsychotics impair manual dexterity in patients with schizophrenia.
    Sasayama D; Hori H; Teraishi T; Hattori K; Ota M; Matsuo J; Kinoshita Y; Okazaki M; Arima K; Amano N; Higuchi T; Kunugi H
    J Psychiatr Res; 2014 Feb; 49():37-42. PubMed ID: 24262979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: a systematic review and meta-analysis.
    Choi YJ
    ScientificWorldJournal; 2015; 2015():970730. PubMed ID: 25664341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of antipsychotic drug action by azapirone 5-HT1A receptor partial agonists: a meta-analysis.
    Kishi T; Meltzer HY; Iwata N
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1259-66. PubMed ID: 23551924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of histamine-2 receptor antagonist adjunction of antipsychotic treatment in schizophrenia: a meta-analysis of randomized placebo-controlled trials.
    Kishi T; Iwata N
    Pharmacopsychiatry; 2015 Jan; 48(1):30-6. PubMed ID: 25321187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis.
    Vernon JA; Grudnikoff E; Seidman AJ; Frazier TW; Vemulapalli MS; Pareek P; Goldberg TE; Kane JM; Correll CU
    Schizophr Res; 2014 Nov; 159(2-3):385-94. PubMed ID: 25240772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis.
    Uchida H; Suzuki T; Takeuchi H; Arenovich T; Mamo DC
    Schizophr Bull; 2011 Jul; 37(4):788-99. PubMed ID: 19946012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review.
    Sim F; Sweetman I; Kapur S; Patel MX
    J Psychopharmacol; 2015 Feb; 29(2):212-23. PubMed ID: 25049261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of
    Goh KK; Wu TH; Chen CH; Lu ML
    J Psychopharmacol; 2021 Mar; 35(3):236-252. PubMed ID: 33406959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials.
    Furukawa TA; Akechi T; Wagenpfeil S; Leucht S
    Schizophr Res; 2011 Mar; 126(1-3):212-9. PubMed ID: 21062670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis.
    Takeuchi H; Thiyanavadivel S; Agid O; Remington G
    Schizophr Res; 2018 Mar; 193():29-36. PubMed ID: 28844639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of Antipsychotic Treatment with Memantine in Patients with Schizophrenia: A Systematic Review and Meta-Analysis.
    Vayısoğlu S; Karahan S; Anıl Yağcıoğlu AE
    Turk Psikiyatri Derg; 2019; 30(4):253-259. PubMed ID: 32594486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.